Skip to content

Now I have a good understanding of the model and relevant information. Let me provide a thorough review of GO-CAM model gomodel:626b20c100000681 - "IL10-mediated signaling pathway (Human)".

Review of GO-CAM Model: IL10-mediated signaling pathway (Human)

Model ID: gomodel:626b20c100000681

Overview

This model represents the IL10-mediated signaling pathway in humans and includes a cascade of molecular interactions starting from IL10 secretion through receptor binding and downstream signaling via JAK1, TYK2, and culminating in STAT3 transcription factor activity.

Model Components

The model includes the following main components: 1. IL10 (P22301) as the cytokine ligand 2. IL10RA (Q13651) as the primary receptor 3. IL10RB (Q08334) as the co-receptor 4. JAK1 (P23458) and TYK2 (P29597) as the receptor-associated kinases 5. STAT3 (P40763) as the downstream transcription factor

Strengths of the Model

  1. Accurate Ligand Representation: IL10 is correctly modeled with cytokine activity (GO:0005125) occurring in extracellular space (GO:0005615) and part of the IL10-mediated signaling pathway.

  2. Proper Receptor Complex: The model accurately represents both IL10RA (primary receptor) and IL10RB (co-receptor) in the plasma membrane, which aligns with known biology and the Signaling Receptor Activity annotation guidelines.

  3. Appropriate Causal Relationships: The model correctly uses "directly positively regulates" (RO:0002629) to connect the signaling cascade from ligand to receptor, receptor to co-receptor, and through to downstream components.

  4. Biological Process Context: All activities are properly part of the IL10-mediated signaling pathway (GO:0140105), providing consistent biological context.

  5. Cellular Compartments: The model correctly specifies the cellular location for each activity (extracellular space for IL10, plasma membrane for receptors, and nucleus for STAT3).

Areas for Improvement

  1. Missing Protein Phosphorylation: The model indicates that JAK1 and TYK2 have protein tyrosine kinase activity, but does not explicitly show which proteins they phosphorylate. Based on the literature, JAK1 should phosphorylate STAT3, but this relationship isn't clearly indicated in the model.

  2. Incomplete Signaling Cascade: The model shows STAT3 as a DNA-binding transcription factor but doesn't indicate what genes it regulates downstream. This makes the model somewhat incomplete from a functional perspective.

  3. Receptor Input Specification: According to the signaling receptor activity guidelines, the receptor's input should be the effector protein it regulates (not the ligand). In this model, explicit "has input" relationships would improve clarity.

  4. Evidence Base: The model relies primarily on two papers (PMID:16982608 and PMID:7543512) for most assertions. While these are appropriate, a broader evidence base would strengthen the model's robustness.

Biological Accuracy

The model accurately represents the canonical IL10 signaling pathway as described in the literature:

  1. IL10 binds to IL10RA, which is consistent with the function of IL10 as an anti-inflammatory cytokine that signals through its receptor.

  2. IL10RA activates IL10RB, forming a receptor heterocomplex, which is biologically accurate.

  3. The receptor complex activates JAK1 and TYK2 kinases, which is consistent with the established signaling mechanism.

  4. STAT3 activation and translocation to the nucleus for transcriptional regulation is the expected outcome of this pathway.

The model is consistent with the known biology of IL10 as described in UniProt: "IL10 binds to its heterotetrameric receptor comprising IL10RA and IL10RB leading to JAK1 and STAT2-mediated phosphorylation of STAT3. In turn, STAT3 translocates to the nucleus where it drives expression of anti-inflammatory mediators."

GO-CAM Best Practices Compliance

The model generally follows GO-CAM best practices:

  1. Signaling Receptor Guidelines: The receptor-ligand relationships follow the guidelines for protein ligand-activated signaling receptors, with the cytokine properly activating the receptor.

  2. Causal Relationships: The use of "directly positively regulates" is appropriate for the signaling cascade represented.

  3. Cellular Context: Each activity has appropriate cellular compartment annotations.

Recommendations for Improvement

  1. Add Phosphorylation Targets: Explicitly show that JAK1 phosphorylates STAT3, using an appropriate causal relationship.

  2. Expand Downstream Effects: Include information about what genes STAT3 regulates to provide a more complete picture of the pathway's functional outcome.

  3. Clarify Input Relationships: According to GO-CAM guidelines, explicitly add "has input" relationships between receptors and their effector proteins.

  4. Include Additional Evidence: Consider incorporating additional supporting literature, especially for the effects of STAT3 activation.

Conclusion

The GO-CAM model gomodel:626b20c100000681 provides a reasonably accurate representation of the IL10-mediated signaling pathway in humans. It follows most GO-CAM best practices and captures key molecular interactions in the pathway. With the suggested improvements, particularly in detailing the downstream effects of STAT3 activation and explicit representation of phosphorylation targets, the model would provide an even more comprehensive representation of this important anti-inflammatory signaling pathway.